Drug repurposing of pyrimidine analogs as potent antiviral compounds against human enterovirus A71 infection with potential clinical applications
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Drug repurposing of pyrimidine analogs as potent antiviral compounds against human enterovirus A71 infection with potential clinical applications
Authors
Keywords
-
Journal
Scientific Reports
Volume 10, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-05-18
DOI
10.1038/s41598-020-65152-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The life cycle of non-polio enteroviruses and how to target it
- (2018) Jim Baggen et al. NATURE REVIEWS MICROBIOLOGY
- Beyond members of the Flaviviridae family, sofosbuvir also inhibits chikungunya virus replication
- (2018) André C. Ferreira et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Seroprevalence of antibodies to enterovirus 71 and coxsackievirus A16 among people of various age groups in a northeast province of Thailand
- (2018) Hatairat Lerdsamran et al. Virology Journal
- Synergistic antiviral activity of Sofosbuvir and type-I interferons (α and β) against Zika virus
- (2017) Beth Snyder et al. JOURNAL OF MEDICAL VIROLOGY
- Gemcitabine, a broad-spectrum antiviral drug, suppresses enterovirus infections through innate immunity induced by the inhibition of pyrimidine biosynthesis and nucleotide depletion
- (2017) Kyungjin Lee et al. Oncotarget
- Sofosbuvir protects Zika virus-infected mice from mortality, preventing short- and long-term sequelae
- (2017) André C. Ferreira et al. Scientific Reports
- Evaluation of Sofosbuvir (β-D-2′-deoxy-2′-α-fluoro-2′-β-C-methyluridine) as an inhibitor of Dengue virus replication #
- (2017) Hong-Tao Xu et al. Scientific Reports
- Direct-acting antivirals and host-targeting strategies to combat enterovirus infections
- (2017) Lisa Bauer et al. Current Opinion in Virology
- Single dose of an adenovirus vectored mouse interferon-α protects mice from lethal EV71 challenge
- (2016) Jialei Sun et al. ANTIVIRAL RESEARCH
- Clinical Pharmacokinetics and Pharmacodynamics of Ledipasvir/Sofosbuvir, a Fixed-Dose Combination Tablet for the Treatment of Hepatitis C
- (2016) Polina German et al. CLINICAL PHARMACOKINETICS
- Protease Inhibitor Resistance Remains Even After Mutant Strains Become Undetectable by Deep Sequencing
- (2016) Hiromi Kan et al. JOURNAL OF INFECTIOUS DISEASES
- Synergistic antiviral activity of gemcitabine and ribavirin against enteroviruses
- (2015) Hyunju Kang et al. ANTIVIRAL RESEARCH
- Safety and tolerability of ledipasvir/sofosbuvir with and without ribavirin in patients with chronic hepatitis C virus genotype 1 infection: Analysis of phase III ION trials
- (2015) Saleh A. Alqahtani et al. HEPATOLOGY
- Phase 1b study of the oral gemcitabine ‘Pro-drug’ LY2334737 in combination with capecitabine in patients with advanced solid tumors
- (2015) Jeffrey R. Infante et al. INVESTIGATIONAL NEW DRUGS
- Phase I dose escalation and pharmacokinetic evaluation of two different schedules of LY2334737, an oral gemcitabine prodrug, in patients with advanced solid tumors
- (2015) Sandrine J. Faivre et al. INVESTIGATIONAL NEW DRUGS
- Recent Progress towards Novel EV71 Anti-Therapeutics and Vaccines
- (2015) Qingyong Ng et al. Viruses-Basel
- Itraconazole Inhibits Enterovirus Replication by Targeting the Oxysterol-Binding Protein
- (2015) Jeroen R.P.M. Strating et al. Cell Reports
- Seroepidemiology of Coxsackievirus A6, Coxsackievirus A16, and Enterovirus 71 Infections among Children and Adolescents in Singapore, 2008-2010
- (2015) Li Wei Ang et al. PLoS One
- Sofosbuvir
- (2014) Lucia Rose et al. ANNALS OF PHARMACOTHERAPY
- Gemcitabine: Metabolism and molecular mechanisms of action, sensitivity and chemoresistance in pancreatic cancer
- (2014) Lucas de Sousa Cavalcante et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Circulation of Coxsackievirus A6 in hand-foot-mouth disease in Guangzhou, 2010-2012
- (2014) Biao Di et al. Virology Journal
- Human Carboxylesterase-2 Hydrolyzes the Prodrug of Gemcitabine (LY2334737) and Confers Prodrug Sensitivity to Cancer Cells
- (2013) S. E. Pratt et al. CLINICAL CANCER RESEARCH
- Gemcitabine sensitizes lung cancer cells to Fas/FasL system-mediated killing
- (2013) Liboria Siena et al. IMMUNOLOGY
- Interferon-induced ISG15 pathway: an ongoing virus–host battle
- (2013) Chen Zhao et al. TRENDS IN MICROBIOLOGY
- HIV-1 Antiretroviral Drug Therapy
- (2013) E. J. Arts et al. Cold Spring Harbor Perspectives in Medicine
- Activity of a Novel Combined Antiretroviral Therapy of Gemcitabine and Decitabine in a Mouse Model for HIV-1
- (2012) Christine L. Clouser et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Obatoclax, Saliphenylhalamide, and Gemcitabine Inhibit Influenza A Virus Infection
- (2012) Oxana V. Denisova et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Gemcitabine versus Modified Gemcitabine: A Review of Several Promising Chemical Modifications
- (2012) Elodie Moysan et al. MOLECULAR PHARMACEUTICS
- Cellular Growth Kinetics Distinguish a Cyclophilin Inhibitor from an HSP90 Inhibitor as a Selective Inhibitor of Hepatitis C Virus
- (2012) Rudolf K. F. Beran et al. PLoS One
- Phase I Study of Oral Gemcitabine Prodrug (LY2334737) Alone and in Combination with Erlotinib in Patients with Advanced Solid Tumors
- (2011) Stijn L.W. Koolen et al. CLINICAL CANCER RESEARCH
- The Deaminated Metabolite of Gemcitabine, 2',2'-Difluorodeoxyuridine, Modulates the Rate of Gemcitabine Transport and Intracellular Phosphorylation via Deoxycytidine Kinase
- (2011) L. S. Hodge et al. DRUG METABOLISM AND DISPOSITION
- Induction Gemcitabine and Stereotactic Body Radiotherapy for Locally Advanced Nonmetastatic Pancreas Cancer
- (2011) Anand Mahadevan et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Hand foot and mouth disease due to enterovirus 71 in Malaysia
- (2011) Kaw Bing Chua et al. VIROLOGICA SINICA
- Discovery of a β-d-2′-Deoxy-2′-α-fluoro-2′-β-C-methyluridine Nucleotide Prodrug (PSI-7977) for the Treatment of Hepatitis C Virus
- (2010) Michael J. Sofia et al. JOURNAL OF MEDICINAL CHEMISTRY
- Amantadine as a regulator of internal ribosome entry site
- (2009) Ying-ju Chen et al. ACTA PHARMACOLOGICA SINICA
- Synthesis, Crystallization, and Biological Evaluation of an Orally Active Prodrug of Gemcitabine
- (2009) David M. Bender et al. JOURNAL OF MEDICINAL CHEMISTRY
- CellProfiler Analyst: data exploration and analysis software for complex image-based screens
- (2008) Thouis R Jones et al. BMC BIOINFORMATICS
- Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer
- (2008) Giorgio Vittorio Scagliotti et al. JOURNAL OF CLINICAL ONCOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started